摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-<4-(1,1-dimethylethyl)phenyl>-4-<4-<<1-<(4-fluorophenyl)methyl>-1H-benzimidazol-2-yl>carbonyl>-1-piperidinyl>-1-butanone | 124443-72-7

中文名称
——
中文别名
——
英文名称
1-<4-(1,1-dimethylethyl)phenyl>-4-<4-<<1-<(4-fluorophenyl)methyl>-1H-benzimidazol-2-yl>carbonyl>-1-piperidinyl>-1-butanone
英文别名
1-[4-(1,1-dimethylethyl)phenyl]-4-[4-[[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl]carbonyl]-1-piperidinyl]-1-butanone;1-(4-tert-butylphenyl)-4-[4-[1-[(4-fluorophenyl)methyl]benzimidazole-2-carbonyl]piperidin-1-yl]butan-1-one
1-<4-(1,1-dimethylethyl)phenyl>-4-<4-<<1-<(4-fluorophenyl)methyl>-1H-benzimidazol-2-yl>carbonyl>-1-piperidinyl>-1-butanone化学式
CAS
124443-72-7
化学式
C34H38FN3O2
mdl
——
分子量
539.693
InChiKey
BFIKKFQTWLJMPW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7
  • 重原子数:
    40
  • 可旋转键数:
    10
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    55.2
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • Process for preparing piperidinyl benzimidazoles
    申请人:Merrell Dow Pharmaceuticals Inc.
    公开号:US05182399A1
    公开(公告)日:1993-01-26
    The present invention is directed to a new class of piperidinyl benzimidazole antihistamines which can be described by the following formula: ##STR1## wherein Y is represented by CO or CHOH; m is an integer from 1 to 2; R is represented by C.sub.1-4 alkyl, C.sub.1-4 alkoxy, halogen, hydroxy and hydrogen; X is represented by hydrogen, COOR.sub.2, in which R.sub.2 is represented by a C.sub.1-4 alkyl, or an alkylene phenyl radical of the formula: ##STR2## wherein T is represented by CHOH, CO, O, or a direct bond; R.sub.1 is represented by C.sub.1-4 alkyl, C.sub.1-4 alkoxy, halogen, hydroxy, 2,2-dimethyl ethanoic acid and hydrogen; n is an integer from 1 to 5; and the pharmaceutically acceptable acid addition salts thereof.
    本发明涉及一种新型的哌啶基苯并咪唑类抗组胺药物,其可由以下公式描述:##STR1## 其中,Y由CO或CHOH表示;m为1至2的整数;R由C.sub.1-4烷基,C.sub.1-4烷氧基,卤素,羟基和氢表示;X由氢,COOR.sub.2(其中,R.sub.2表示C.sub.1-4烷基,或具有以下公式的烷基苯基基团:##STR2## 其中,T由CHOH,CO,O或直接键表示;R.sub.1由C.sub.1-4烷基,C.sub.1-4烷氧基,卤素,羟基,2,2-二甲基乙酸和氢表示;n为1至5的整数;以及其药学上可接受的酸盐。
  • Piperidinyl benzimidazoles as antihistamines
    申请人:MERRELL DOW PHARMACEUTICALS INC.
    公开号:EP0363963A1
    公开(公告)日:1990-04-18
    Piperidinyl benzimidazole antihistamines, of the formula: wherein Y is represented by CO or CHOH; m is an integer from 1 to 2; R is represented by alkyl, alkoxy, halogen, hydroxy and hydrogen, X is represented by hydrogen, COOR₂ in which R₂ is represented by alkyl, or X is an alkylene phenyl radical of the formula: wherein T is represented by CHOH, CO, O, or a direct bond; R₁ is represented by alkyl, alkoxy, halogen, hydroxy, 2,2-dimethyl ethanoic acid and hydrogen; n is an integer from 1 to 5; or a pharmaceutically acceptable acid addition salt thereof.
    哌啶基苯并咪唑抗组胺剂,其式如下 其中 Y 由 CO 或 CHOH 表示;m 是 1 至 2 的整数;R 由烷基、烷氧基、卤素、羟基和氢表示,X 由氢、COOR₂表示,其中 R₂ 由烷基表示,或 X 是式中的亚烷基苯基自由基: 其中 T 代表 CHOH、CO、O 或直接键;R₁ 代表烷基、烷氧基、卤素、羟基、2,2-二甲基乙酸和氢;n 为 1 至 5 的整数;或其药学上可接受的酸加成盐。
  • US4908372A
    申请人:——
    公开号:US4908372A
    公开(公告)日:1990-03-13
  • US5182399A
    申请人:——
    公开号:US5182399A
    公开(公告)日:1993-01-26
  • Antihistaminic piperidinyl benzimidazoles
    申请人:Merrell Dow Pharmaceuticals Inc.
    公开号:US04908372A1
    公开(公告)日:1990-03-13
    The present invention is directed to a new class of piperidinyl benzimidazole antihistamines which can be described by the following formula: ##STR1## wherein Y is represented by CO or CHOH; m is an integer from 1 to 2; R is represented by C.sub.1-4 alkyl, C.sub.1-4 alkoxy, halogen, hydroxy and hydrogen, X is represented by hydrogen, COOR.sub.2 in which R.sub.2 is represented by a C.sub.1-4 alkyl, or X is an alkylene phenyl radical of the formula: ##STR2## wherein T is represented by CHOH, CO, O, or a direct bond; R.sub.1 is represented by C.sub.1-4 alkyl, C.sub.1-4 alkoxy, halogen, hydroxy, 2,2-dimethyl ethanoic acid and hydrogen; n is an integer from 1 to 5; or a pharmaceutically acceptable acid addition salt thereof.
    该发明涉及一种新型哌啶基苯并咪唑类抗组胺剂,其可用以下结构表示: 其中Y表示CO或CHOH;m是1到2的整数;R表示C.sub.1-4烷基,C.sub.1-4烷氧基,卤素,羟基和氢,X表示氢,COOR.sub.2,其中R.sub.2表示C.sub.1-4烷基,或X是下述结构的烷基苯基基团: 其中T表示CHOH,CO,O,或直接键;R.sub.1表示C.sub.1-4烷基,C.sub.1-4烷氧基,卤素,羟基,2,2-二甲基乙酸和氢;n是1到5的整数;或其药学上可接受的酸盐。
查看更多